by adminAdrianRamirez | Jan 9, 2020 | Axim Biotechnologies, Press Releases
SAN DIEGO, Jan. 9, 2020 /PRNewswire/ — Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products,...
by adminAdrianRamirez | Sep 12, 2019 | Axim Biotechnologies, Press Releases
SAN DIEGO, Sept. 12, 2019 — Medical Marijuana, Inc. (OTC:MJNA) (“the Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply...
by adminAdrianRamirez | Jun 13, 2019 | Axim Biotechnologies, Press Releases
SAN DIEGO, June 13, 2019 — Medical Marijuana, Inc. (OTC:MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply...
by adminAdrianRamirez | May 14, 2019 | Axim Biotechnologies, Press Releases
NEW YORK, May 14, 2019 — Medical Marijuana, Inc. (MJNA), the first-ever publicly traded cannabis company in the United States, today announced that the Company’s major investment company AXIM® Biotechnologies, Inc. (AXIM) (“AXIM”), a world...
by adminAdrianRamirez | Apr 10, 2019 | Axim Biotechnologies, Press Releases
SAN DIEGO, April 10, 2019 — Medical Marijuana, Inc. (OTC:MJNA), the first-ever publicly traded cannabis company in the United States, announced that its investment company AXIM® Biotechnologies (“AXIM® Biotech” or “AXIM”) (OTCQB:AXIM), a...